World Orphan Drug Congress 2026

UBC is proud to participate in the World Orphan Drug Congress USA, the leading event dedicated to rare disease therapies and orphan drug development. This conference brings together global stakeholders to address challenges in clinical research, regulatory compliance, patient access, and commercialization for rare conditions.

UBC partners with sponsors to deliver integrated solutions that combine evidence generation, risk management, and patient access strategies. Our expertise ensures that rare disease programs are supported by robust real-world data, compliant safety operations, and patient-centric access solutions throughout the product lifecycle.

• Evidence Development Solutions: Registries, observational studies, and real-world evidence strategies tailored for rare disease programs.
• Safety & Risk Management: REMS program design and implementation, risk minimization strategies, and global pharmacovigilance./li>
• Patient Access Solutions: Affordability programs, benefit verification, and adherence support to remove barriers to care.
• Integrated Approach: Linking evidence generation, safety, and access for comprehensive program support.
• Rare Disease Expertise: Proven experience in complex programs across diverse therapeutic areas.

Connect with UBC at the World Orphan Drug Congress USA to learn how our solutions can support your rare disease initiatives.